Table 3 Subgroup analysis of the association between eGDR and risk of CVD
Characteristics | eGDR(mg/kg/min) | P value | P-interaction | |||
|---|---|---|---|---|---|---|
< 8.92 | 8.92–10.41 | 10.41–11.26 | ≥ 11.26 | |||
Sex | ||||||
Male | 1.00(Ref) | 0.91(0.74–1.13) | 0.70(0.57–0.87) | 0.59(0.47–0.74) | < 0.001 | 0.005 |
Female | 1.00(Ref) | 0.98(0.83–1.16) | 0.67(0.55–0.82) | 0.57(0.46–0.70) | < 0.001 | |
Diabetes | ||||||
No | 1.00(Ref) | 0.98(0.85–1.13) | 0.70(0.60–0.81) | 0.59(0.50–0.69) | < 0.001 | 0.110 |
Yes | 1.00(Ref) | 0.97(0.45–2.09) | 0.89(0.50–1.58) | 0.75(0.56–0.96) | 0.003 | |
Age, years | ||||||
< 60 | 1.00(Ref) | 0.91(0.76–1.10) | 0.64(0.52–0.78) | 0.55(0.44–0.68) | < 0.001 | < 0.001 |
≥ 60 | 1.00(Ref) | 1.04(0.87–1.25) | 0.78(0.63–0.95) | 0.65(0.53–0.81) | < 0.001 | |
Place of residence | ||||||
Urban | 1.00(Ref) | 0.87(0.74–1.04) | 0.66(0.55–0.78) | 0.57(0.47–0.68) | < 0.001 | 0.681 |
Rural | 1.00(Ref) | 1.10(0.89–1.36) | 0.73(0.56–0.93) | 0.57(0.43–0.76) | < 0.001 | |
Smoking | ||||||
No | 1.00(Ref) | 0.97(0.82–1.14) | 0.68(0.57–0.82) | 0.59(0.48–0.72) | < 0.001 | 0.465 |
Yes | 1.00(Ref) | 0.93(0.75–1.16) | 0.69(0.55–0.87) | 0.57(0.45–0.72) | < 0.001 | |
Drinking | ||||||
No | 1.00(Ref) | 0.99(0.84–1.17) | 0.70(0.58–0.84) | 0.61(0.50–0.74) | < 0.001 | 0.954 |
Yes | 1.00(Ref) | 0.90(0.72–1.11) | 0.68(0.54–0.85) | 0.54(0.42–0.69) | < 0.001 | |
Education level, n (%) | ||||||
Below primary school | 1.00(Ref) | 0.98(0.78–1.23) | 0.67(0.52–0.87) | 0.60(0.46–0.78) | < 0.001 | 0.114 |
Primary school | 1.00(Ref) | 0.98(0.79–1.21) | 0.73(0.58–0.91) | 0.55(0.43–0.71) | < 0.001 | |
Middle school | 1.00(Ref) | 1.07(0.78–1.47) | 0.72(0.51–1.02) | 0.69(0.47–0.98) | 0.022 | |
High school or above | 1.00(Ref) | 0.73(0.49–1.09) | 0.67(0.43–1.04) | 0.52(0.32–0.84) | 0.002 | |
Anti-diabetes/hypertension drugs | ||||||
No | 1.00(Ref) | 0.91(0.79–1.05) | 0.66(0.57–0.77) | 0.56(0.47–0.65) | < 0.001 | 0.002 |
Yes | 1.00(Ref) | 1.02(0.66–1.29) | 0.94(0.56–1.09) | 0.58(0.43–0.77) | 0.005 | |